Close up of senior woman using cannabis at home (Getty/Emilija Manevska)
(WASHINGTON) — Acting Attorney General Todd Blanche signed an order on Thursday reclassifying state-licensed medical marijuana as a less dangerous drug.
The order moves marijuana from Schedule I to Schedule III, putting state-licensed medical marijuana in the same category as some pain medications, ketamine and testosterone.
Schedule I drugs are defined as “drugs with no currently accepted medical use and a high potential for abuse” while Schedule III drugs are defined as “drugs with a moderate to low potential for physical and psychological dependence,” according to the Drug Enforcement Agency (DEA).
While this change aligns federal guidelines with many state laws, marijuana is still illegal at the federal level. It does not remove cannabis from the federal controlled substance list, legalize recreational use nationwide or allow unregulated sales similar to tobacco and alcohol.
However, the move could allow for expanded research and ease many of the tax and regulatory rules placed on the cannabis industry.
“These actions will enable more targeted, rigorous research into marijuana’s safety and efficacy, expanding patients’ access to treatments and empowering doctors to make better-informed healthcare decisions,” Blanche wrote in a statement on X.
President Donald Trump announced late last year that his administration would seek to reclassify marijuana, but not legalize it for medical or recreational use under federal statutes. Over the weekend, the president appeared to express frustration that the administration was slow-walking the effort.
Blanche said the Justice Department and DEA will begin the process of potentially reclassifying all marijuana to Schedule III. The DEA is planning to hold a hearing in late June.
“The new hearing … will provide a timely and legally compliant pathway to evaluate broader changes to marijuana’s status under federal law,” according to a press release from the Justice Department.
The process of reclassifying marijuana began under the administration of former President Joe Biden.
In October 2022, Biden asked then-Secretary of Health and Human Services (HHS) Xavier Becerra and then-Attorney General Merrick Garland “to initiate the administrative process to review expeditiously how marijuana is scheduled under federal law.”
The HHS in August 2023 made a recommendation to the DEA to move medical marijuana from Schedule I to Schedule III.
In May 2024, the Justice Department announced Garland had submitted a notice of proposed rule-making to move medical marijuana to Schedule III, with DEA announcing in August 2024 that a hearing would be held on the proposal.
That hearing was scheduled to begin on Jan. 21, 2025, but was postponed about a week before by a judge.
Marijuana is the most widely used federally illegal drug in the country. Nearly one in five Americans — 52.5 million people — reported using it at least once in 2021, according to the Centers for Disease Control and Prevention (CDC).
So far, 24 states and the District of Columbia have fully legalized recreational marijuana for adults, allowing adults aged 21 and older to possess, use and, in most cases, cultivate small amounts of cannabis, according to the National Conference of State Legislatures.
Although cannabis may have potential medical uses, it has also been associated with mental health problems, impaired driving, and lung and heart conditions. About three in 10 cannabis users will develop cannabis use disorder, meaning they are unable to stop using cannabis even though it’s causing health and social problems, according to the CDC.
Cannabis use directly affects the parts of the brain responsible for memory, learning, attention and decision-making, the CDC says.
The CDC also cautions that it can cause harm to brain development in young people and use during pregnancy may be linked to lower birth weight and possible developmental effects.
Stock photo of people commuting on e-bikes and scooters. (Maskot/STOCK PHOTO/Getty Images)
(NEW YORK) — E-bikes and e-scooters led to a growing number of trauma injuries at one New York City hospital, according to a new study published Wednesday.
About 7% of all trauma visits between 2018 and 2023 at Bellevue Hospital Center were due to micromobility injuries. Micromobility is the use of small, lightweight and low-speed modes of transportation such as bicycles, e-bikes and e-scooters.
The study showed a growing share of patients who sustained these injuries had accidents linked to e-bikes or e-scooters.
Hospital data showed that, by 2023, over half of all trauma cases related to bikes or scooters involved an e-bike or e-scooter, an increase from just 8% in 2018, according to the study, published in the journal Neurosurgery.
The most common type of mechanism involved a collision with a motor vehicle followed by falls from the bike or scooter.
Bellevue is a Level 1 Trauma center in a large metropolitan city, designed to treat the worst kinds of injuries. Over the study period, about 30% of patients suffered a traumatic brain injury, 26% had injury to the skull or face and 50% required surgery.
“Our study shows that micromobility injuries are producing serious brain and spinal trauma that demands neurosurgical care at a scale we haven’t seen before,” corresponding study author Dr. Hannah Weiss, a resident in the Department of Neurosurgery at NYU Grossman School of Medicine, said in a press release. “In a busy urban setting, we are seeing more and more of these injuries firsthand.”
Most patients seen for these injuries, nearly 69%, needed to be admitted to the hospital and nearly a third needed intensive care.
The majority of patients stayed at least three days in the hospital. Pedestrians who were struck had higher rates of traumatic brain injuries and were more likely to be admitted for intensive care.
“The data point to actionable solutions — helmet use, safer bike lane design and enforcement — that could prevent many of these injuries and better protect both riders and pedestrians, who in our study often sustained even more severe brain injuries than the riders themselves,” Weiss said.
About 20% of patients were intoxicated with alcohol, only 31% were using a helmet and injuries were more likely to occur in the evening hours, according to the study.
“Our findings make clear that urban infrastructure must continue to improve to keep pace with the rapid rise of electric bikes and scooters,” Dr. Paul P. Huang, an associate professor in the department of neurosurgery at NYU Grossman School of Medicine and chief of neurosurgery at NYC Health + Hospitals/Bellevue, said in a press release.
“Future studies should track these injuries across multiple cities and measure whether protected bike lanes, helmet programs, and speed enforcement actually reduce the number of brain and spine surgeries we perform,” Huang added,
Jade A. Cobern, MD, MPH, is a practicing physician, board-certified in pediatrics and general preventive medicine, and is a fellow of the ABC News Medical Unit.
Robert Kennedy Jr. appears before the Senate Finance Committee at the Dirksen Senate Office Building on September 04, 2025 in Washington, DC. (Andrew Harnik/Getty Images)
(WASHINGTON) — Health and Human Services Secretary Robert F. Kennedy Jr. heads to Capitol Hill Thursday after restoring staffing at the World Trade Center Health Program, a move that could ease one of the most persistent points of bipartisan criticism he has faced for months.
Program advocates and lawmakers said they received an email from the secretary on Wednesday approving hiring for 37 long-vacant positions. This will raise staffing from its current 83 employees to the federally authorized level of 120.
The move comes after nearly a year of bipartisan criticism that staffing shortages were slowing care for the 140,000 responders and survivors the program serves, many of whom have been diagnosed with cancer, respiratory disease and other conditions tied to exposure to toxins after the 9/11 terror attacks in New York, Shanksville, Penn., and Washington, D.C.
The World Trade Center Health Program was created as part of the James Zadroga 9/11 Health and Compensation Act to provide long-term medical monitoring and treatment to those affected by the attacks. For more than a year, the program has operated far below capacity with about 83 staff members, following a period of upheaval that included firings, rehires and shifting leadership, even as the participant population grew by nearly 30,000 new enrollees.
Advocates say the reduced staffing has had real consequences, including slower approval of survivors into the program, delays in managing contractors, and longer wait times for care.
“This is progress,” Benjamin Chevat, executive director of Citizens for the Extension of the James Zadroga Act, told ABC News. He credited the progress to sustained pressure from lawmakers in both parties and their consistent support of the program.
Lawmakers also have welcomed the end of the hiring freeze.
Rep. Andrew Garbarino, R-N.Y., told ABC News that the approval for the additional staff would “directly support the responders and survivors who rely on this care every day,” and that “more staff means better access to care, shorter wait times, and stronger support for those still living with the health impacts” of the attacks.
He called the move “real progress for the 9/11 community” and said it is “about making sure those who answered the call on September 11th get the care they have earned.”
Rep. Dan Goldman, D-N.Y., also welcomed the news but criticized the delays. “I am encouraged that, after repeated demands from me and from other members of Congress, Secretary Kennedy is finally increasing staffing at the World Trade Center Health Program so that our brave survivors and first responders can receive the quality health care they deserve,” Goldman told ABC News.
“The ongoing staffing shortages under this administration are unacceptable and have been undermining the program’s ability to provide timely and quality care to the enrollees,” Goldman added. “I will be watching closely to ensure that new staffers are hired as quickly as possible and that our heroes receive the quality healthcare they were promised and deserve.”
At a senate hearing last May, Kennedy acknowledged that “we made a couple of mistakes” in firing program staff and promised to address them.
“Under Secretary Kennedy’s leadership, the World Trade Center Health Program continues to move forward and deliver for responders and survivors,” a spokesperson for the Department of Health and Human Services told ABC News in response to a request for comment. “The approval of these positions reflects HHS’ commitment to strengthening the program. The petition reviews are proceeding through established processes, and work is actively underway to advance pending petitions. Protecting the health and well-being of those affected by 9/11 remains a top priority.”
Chevat pointed out the timing of the decision, which comes as Kennedy prepared to face lawmakers at Thursday’s public hearing: “Now a year later he is finally letting the program fill the staff vacancies that the program was blocked from filling.”
In a previous statement to ABC News, HHS spokesperson Andrew Nixon said decisions about the program, including staffing and whether to add new health conditions to be covered under the program, rest with the World Trade Center Health Program administrator, not Secretary Kennedy.
Even with the staffing issue moving toward resolution, significant concerns for the program remain, Chevat said. They include key decisions about expanding coverage for additional conditions including autoimmune, cardiac, and cognitive disorders are still pending – for years, in some cases.
Those decisions ultimately require sign-off within HHS, under Kennedy’s direction, according to Chevat. Until that happens, patients with those conditions don’t qualify for full coverage through the program.
Research funding for the program also remains stalled, according to Chevat. Its annual grant cycle, which typically distributes about $20 million for studies on 9/11-related illnesses, is still waiting for approval, despite the understanding that it would begin this past February, he said.
Additionally, communication between the program and the 9/11 community has been sparse under HHS oversight, with fewer updates and less clarity about decision-making, according to Chevat and other 9/11 survivor advocates.
Lawmakers are still likely to ask Kennedy questions about the World Trade Center Health Program during today’s hearings, Chevat said. The research funding budget is also expected to come up during a Senate Health, Education, Labor and Pensions Committee hearing next week.
For now, however, the decision to restore program staffing removes one of the most visible and widely criticized problems, Chevat said.